Search

everythinglearnresearchcommunity

for

Search:↓

Researchers found four natural compounds that can change DHT levels in prostate cancer cells.

RADA16-I can effectively deliver and release mangiferin, improving its solubility and bioavailability.

Electrical stimulation with minoxidil boosts hair cell growth.

Forensic DNA phenotyping can help generate new leads in cold cases but faces accuracy, legal, and acceptance challenges.

Hair follicles repair 3D injuries using a 2D healing process.

Accurate diagnosis and management of rare genian fistulas require combined clinical, radiologic, and histopathologic evaluations.

Finasteride may treat baldness but less effective for those with 5α-reductase deficiency.

Combining red LED therapy with beta-carotene is more effective for treating photoaging than red LED therapy alone.

Lgr5 and the vitamin D receptor are key in controlling skin inflammation and tumor risk in mice.

The gene GJA1 is important for regulating coarse hair density in goats.

The document's conclusion cannot be provided because the document is not available or cannot be read.

RXRa is crucial for Th2 immune cell development and may link nutrition to immune health.

A unique gene mutation causes vitamin D-resistant rickets without causing hair loss.

A new mouse mutation causes skin and hair issues, influenced by another gene.

A person had two different benign skin tumors, a trichoadenoma and melanocytic naevi, at the same time but in different places on the face.

A new genetic mutation linked to CARASIL syndrome and small artery disease was found in a Chinese family.

A gene called Gk5 controls lipid production in the skin and affects hair growth.

Activating Tgr5 may help treat hair loss and bone loss.

Using both minoxidil and biotin together increased hair growth more than using either one alone.

DHT is a strong androgen that may pose less risk to the prostate compared to testosterone.

Ablative fractional laser treatment nearly matches the gene reduction effects of topical vismodegib in skin cancer.

Hexahydrobenzo[f]quinolines are effective at blocking the enzyme 5α-reductase.